Medical Oncologist
Second opinion
What a Good Second Opinion — Actually Checks
A second opinion is not a second doctor reading the same notes. It is a structured review of whether the right tests were done, the right stage was assigned, and the right plan was reached. This audit tells you what to look for and what to ask.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Not just a read-through — A thorough second opinion re-examines the pathology slides, imaging and testing — not only the summary from the first team.
- Ten specific checkpoints — There are ten documented areas where gaps are most likely to change a treatment plan.
- Disagreement is useful — If the second opinion differs, that tells you where the uncertainty is — and what needs clarifying before you start.
- ASCO and ESMO support it — Both bodies explicitly support patients seeking independent review before starting treatment for a new cancer diagnosis.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
A second opinion reviews your pathology, staging, imaging, biomarker and molecular testing, and whether your treatment plan follows current NCCN, ASCO or ESMO guidelines for your specific cancer and stage. It is not a repeat of the first consultation. It is a structured check of whether every decision point was reached on complete and accurate information.
What does a second opinion actually review?
A thorough second opinion reviews your pathology, your staging, your imaging, and whether your treatment plan aligns with current guidelines for your cancer type and stage.
It starts with the biopsy slides themselves, not just the report that summarises them. It checks whether all the relevant biomarker and molecular tests were ordered and correctly interpreted. It then asks whether the recommended treatment matches NCCN, ASCO or ESMO evidence for your specific case.
That comparison — plan against guideline — is where gaps most commonly appear.
Which ten things should a second opinion review?
- Pathology re-readAn independent pathologist examines the biopsy slides directly, not just the original written report.
- Diagnosis confirmedThe cancer type and subtype are verified, including any rare or unusual features that change how it is managed.
- Staging verifiedThe stage is checked against current AJCC or equivalent criteria and against your actual scan images.
- Imaging re-readA radiologist experienced in your cancer type reviews the scan images independently of the original report.
- Biomarker testing completenessAll relevant markers for your cancer type — PD-L1, HER2, EGFR, MSI and others — are confirmed as tested and correctly read.
- Molecular or genomic testingWhere relevant, the tumour is checked for actionable mutations that could change which treatment fits best.
- Guideline alignmentThe proposed treatment is checked against NCCN, ASCO or ESMO guidance for your specific cancer type, stage and molecular profile.
- Multidisciplinary inputSurgical, medical and radiation oncology have all reviewed the case, not only the single specialty that first saw you.
- Clinical trial eligibilitySomeone has actively checked whether you qualify for an ongoing trial before confirming the standard treatment plan.
- Late effects and fertility discussionWhere relevant, fertility preservation, late effects and supportive care options have been explained before treatment begins.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What happens if the second opinion disagrees with the first?
Disagreement between two oncologists is information, not a problem. It tells you where uncertainty exists in your case and what needs to be resolved before you start.
Sometimes the pathology changes — the cancer subtype is reclassified and a different treatment fits better. Sometimes the stage changes. Sometimes both plans are reasonable and the difference reflects genuine clinical uncertainty rather than error.
Ask each team to explain specifically which fact or guideline their plan rests on. Understanding that difference tells you whether a third opinion, a joint case discussion, or further testing is the right next step.
Surface check versus full audit: what is the difference?
| Area reviewed | Surface check | Full audit |
|---|---|---|
| Pathology | Accepts the original written report | Independent re-read of the biopsy slides by a specialist pathologist |
| Staging | Takes the assigned stage at face value | Verified against current criteria and the actual scan images |
| Imaging | Reads the existing radiology report | Specialist radiologist re-reads the scan images independently |
| Biomarker testing | Notes whether testing was done | Confirms all relevant markers for your cancer type were ordered and correctly interpreted |
| Treatment plan | Checked against one guideline | Cross-referenced against NCCN, ASCO and ESMO for your cancer, stage and molecular profile |
| Multidisciplinary input | One specialist's view | Surgical, medical and radiation oncology all reviewed the case |
| Clinical trial eligibility | Rarely checked | Confirmed before the treatment plan is finalised |
Did you know?
ASCO guidance supports independent pathology review before treatment starts for any new cancer diagnosis. Pathology is the foundation of every decision that follows — the cancer type, the stage, the biomarkers, and the treatment plan all rest on it.
A revised pathology result does not always mean the first team made an error. It often means the diagnosis has been made more precisely.
Source: American Society of Clinical Oncology (ASCO) — guidance on second opinions in oncology
Explore 52 more Cost, Access, Trials & Choosing a Hospital topics
Hospital Choice, Second Opinion & Decision Pages
- A Guide for International and NRI Patients Seeking Cancer Care in India
- Day Care Infusion Centres: What to Expect on Infusion Day
- Documents to Bring to Your First Oncology Consultation
- Follow-Up on Oral Targeted Therapy: In Person or Teleconsult?
- Getting a Second Opinion on Your Targeted Therapy Plan
- How a Molecular Tumour Board Reviews Your Case
- How to Choose a Hospital for Targeted Therapy in India
- Medical Oncologist vs Precision Oncology Specialist: Who Do You Need?
- Online and Teleconsultation Second Opinions: How They Work
- Red Flags: Signs Your Cancer Care May Not Be Up to Standard
- Transferring Your Care to Another Hospital Mid-Treatment
- What a Good Second Opinion Actually Checks: A 10-Point Audit
- What a Precision Oncology Program Should Include: A Checklist
- What to Ask Before Committing to a Cancer Treatment Plan
Clinical Trials & Access Programs
- Basket and Umbrella Trials: The New Way Trials Are Designed
- Eligibility Criteria: Why Patients Get Rejected From Trials
- How to Find Cancer Clinical Trials in India
- Phase 1, 2 and 3 Trials: What the Numbers Mean for You
- Risks, Consent and Your Right to Withdraw
- What Happens After a Trial Ends?
- What Is a Clinical Trial and Should You Join One?
- Who Pays for Treatment in a Clinical Trial?
- Will I Get a Placebo Instead of Real Treatment?
Cost, Insurance & Access in India
- Are Generic Targeted Therapy Drugs Safe and Effective?
- Biosimilars for Trastuzumab, Bevacizumab and Rituximab in India
- CGHS, ECHS, ESI and State Schemes for Cancer Drugs
- Can You Get Targeted Therapy in a Government Hospital?
- Compassionate Access and Expanded Access Programs Explained
- Cost of NGS Testing vs the Cost of Treating Blindly
- Cost of Targeted Therapy in India: Monthly Price Guide by Drug Class
- Does Ayushman Bharat Cover Targeted Therapy?
- Hidden Costs Nobody Warns You About in Cancer Treatment
- How to File a Cancer Treatment Insurance Claim Without Rejection
- How to Talk to Your Doctor About Affording Treatment
- Importing a Cancer Drug Not Available in India
- NGOs and Crowdfunding for Cancer Treatment in India
- Patient Assistance Programs for Targeted Therapy Drugs in India
- Section 80DDB and Tax Deductions for Cancer Treatment
- Total Cost of Care: Targeted Therapy vs Chemotherapy Compared
- What Happens If You Have to Stop Treatment Because of Cost?
- Will Health Insurance Pay for Oral Cancer Tablets Taken at Home?
Work, Travel, Legal & Insurance Rights
- Buying Life or Health Insurance After a Cancer Diagnosis
- Can You Keep Working Full Time on Targeted Therapy?
- Disability Certificate for Cancer Patients in India: How to Apply
- Flying With Cancer: Fitness to Fly and Airline Rules
- Making a Will and Organising Documents During Serious Illness
- Managing Fatigue and Meetings: Practical Workday Strategies
- Planning a Holiday Around Your Treatment Schedule
- Returning to Work After a Treatment Break
- Should You Tell Your Employer About Your Cancer Diagnosis?
- Sick Leave and Employment Rights for Cancer Patients in India
- Travel Insurance When You Have Cancer
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Does getting a second opinion upset my first oncologist?
It should not, and any oncologist following professional standards will support your right to one. ASCO guidance is explicit that seeking a second opinion is a reasonable and appropriate step before starting treatment for a new cancer diagnosis. If your current team discourages it, that is itself useful information. Most oncologists find that a second opinion, when it agrees with the first, gives their patients more confidence in the plan they are about to follow.
How long does a second opinion take?
A thorough second opinion typically takes one to two weeks from when the reviewing centre receives your complete records, scans and biopsy material. The longest part is usually gathering and transferring the original slides and imaging. If treatment genuinely cannot wait, say so when you contact the reviewing centre — they can tell you whether the timeline is compatible with starting and whether anything can be prioritised.
Do I need to bring the actual biopsy slides or just the written reports?
Bring the slides, not only the reports. The report summarises what one pathologist saw at one point in time. The slides allow an independent pathologist to examine the same tissue and reach their own conclusion. Request the physical slides or a digital scanned copy from the laboratory that did your biopsy — most hospitals will release them on request. Bring your imaging CD or disc as well, so the radiologist can re-read the images rather than the existing report.
What if the two opinions disagree?
Ask each team to explain specifically which fact or guideline their recommendation rests on. Disagreements between experienced oncologists usually come down to one of three things: a difference in how the pathology is read, a difference in how the stage is interpreted, or a genuine difference in clinical judgement where more than one approach is supported by evidence. Understanding which of these is driving the difference tells you whether a third opinion, a joint discussion between both teams, or further testing is the right next step.
Will a second opinion delay my treatment?
For most solid tumours, one to two weeks does not meaningfully change outcomes, and ASCO and ESMO both support taking that time to confirm the plan before starting. Your first oncologist can advise whether your specific situation is one where delay is a concern. If treatment is genuinely urgent, the reviewing centre can often prioritise the most time-sensitive question — usually the pathology — before the full review is complete.
How do I know the second opinion oncologist has seen my cancer type before?
Ask directly. Relevant questions are: how many patients with this cancer type the oncologist sees in a year, whether the centre holds a multidisciplinary tumour board for this cancer, and whether the pathology will be read by a pathologist who specialises in this tumour type. Volume matters because rarer presentations and subtleties in biomarker interpretation are more likely to be recognised at centres that see this cancer regularly.